---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-040048"
form_type: "8-K"
ticker: "BLFS"
cik: "0000834365"
company_name: "BIOLIFE SOLUTIONS INC"
filed_at: "2026-06-03T12:03:31+00:00"
generated_at: "2026-06-03T12:05:10.404575+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# BioLife Solutions issues investor presentation for Jefferies conference; no material updates disclosed

## Summary
- Presentation dated June 3, 2026, furnished as Exhibit 99.1.
- Available on company website and used at Jefferies Global Healthcare Conference.
- No new financial guidance, business updates, or key metrics provided in the filing.
- Presentation cover cites 'Industry-Leading Solutions for Cell-Based Therapies'.

## SEC filing metadata
- accession: 0001628280-26-040048
- form_type: 8-K
- ticker: BLFS
- cik: 0000834365
- company_name: BIOLIFE SOLUTIONS INC
- filed_at: 2026-06-03T12:03:31+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/834365/000162828026040048/0001628280-26-040048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/834365/000162828026040048/blfs-20260603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-040048
- JSON: https://secwatch.observer/filing/0001628280-26-040048.json
- Plain text: https://secwatch.observer/filing/0001628280-26-040048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.